<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03277326</url>
  </required_header>
  <id_info>
    <org_study_id>2017/2459</org_study_id>
    <nct_id>NCT03277326</nct_id>
  </id_info>
  <brief_title>Interscalene vs Anterior and Posterior Suprascapular Nerve Block for Shoulder Arthroscopic Surgeries</brief_title>
  <official_title>Randomised, Controlled Trial Comparing Interscalene Versus Anterior and Posterior Approaches of Suprascapular Nerve Block for Shoulder Arthroscopic Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changi General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changi General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare ISB vs anterior and posterior approaches of suprascapular block in terms of lung
      function and analgesia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interscalene block (ISB) is commonly used to provide pain control for shoulder surgeries.
      However, it is associated with several side effects, in particular, a high incidence of
      phrenic nerve blockade.

      The suprascapular nerve block (SSB) has been proposed as an alternative to the ISB as it has
      a lower likelihood of causing phrenic nerve blockade. There are 2 commonly used approaches
      for the suprascapular nerve block, anterior and posterior. The anterior approach may still
      result in some degree of impairment of lung function.

      Our primary aim is to assess the pulmonary function after performance of ISB, aSSB and pSSB.
      Secondary outcomes are analgesic effects and incidence of adverse effects of these blocks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 30, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary function</measure>
    <time_frame>2 years</time_frame>
    <description>To assess the pulmonary function after performance of interscalene, anterior and posterior approaches to the suprascapular block</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analgesic effects and complications</measure>
    <time_frame>2 years</time_frame>
    <description>Analgesic effect (pain scores, opioid consumption, opioid related side effects), degree of motor blockade and incidence of adverse effects of blocks (Horner's syndrome, hoarseness of voice)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Arthroscopic Shoulder Surgery</condition>
  <condition>Interscalene Block</condition>
  <condition>Suprascapular Nerve Block</condition>
  <arm_group>
    <arm_group_label>ISB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Interscalene brachial plexus block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>aSSB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anterior Suprascapular Block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pSSB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Posterior Suprascapular Block</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ISB</intervention_name>
    <description>ISB block with 0.5% ropivicaine 15mls ( 45mg )</description>
    <arm_group_label>ISB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>aSSB</intervention_name>
    <description>aSSB block with 0.5% ropivicaine 15mls ( 45mg )</description>
    <arm_group_label>aSSB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pSSB</intervention_name>
    <description>pSSB block with 0.5% ropivicaine 15mls ( 45mg )</description>
    <arm_group_label>pSSB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective arthroscopic shoulder surgery under general
             anaesthesia

          -  Patients 21 years old and above

          -  American Society of Anesthesiologists (ASA) physical status 1 to 3

        Exclusion Criteria:

          -  Patients unable to give consent or inability to communicate/ cooperate

          -  Patients with chronic use of strong opioids (morphine, oxycodone)

          -  Patients with allergy to local anaesthetics or any drugs included in the study

          -  Patients with contraindications for regional anaesthesia such as coagulopathy

          -  Patients with pre-existing neurological deficits in upper limb/ phrenic nerve palsy

          -  Patients with pre-existing lung disease (COPD, uncontrolled asthma)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yean Chin Lim</last_name>
    <role>Principal Investigator</role>
    <affiliation>CGH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>CTRU</last_name>
    <phone>67888833</phone>
    <email>ctru@cgh.com.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Changi General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>529889</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CTRU CGH</last_name>
      <phone>67888833</phone>
    </contact>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2017</study_first_submitted>
  <study_first_submitted_qc>September 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2017</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

